User:Adel Attari/sandbox

From Wikipedia, the free encyclopedia

Antibiotic Properties of Nanoparticles[edit]

Nano particles have been studied extensively for their antimicrobial properties in order to fight super bug bacteria. Several characteristics in particular make nano particles strong candidates as a traditional antibiotic drug alternative:

  • A high surface area to volume ratio which increases contact area on an organism [1][2]
  • May be synthesized from polymers, lipids, and metals [1]
  • A multitude of chemical structures, such as fullerenes or metal oxides, allow for a diverse set of chemical functionalizations

The key to nanoparticle efficacy against antibiotic resistant strains of bacteria lies in their small size. On the nano scale, particles can behave as molecules when interacting with a cell which allows them to easily penetrate the cell membrane and interfere in vital molecular pathways if the chemistry is possible. [3]

Metal Nanoparticles[edit]

A strong research focus has been placed on triggering excessive reactive oxygen species (ROS) production using nanoparticles injected in bacterial cells. The presence of excessive ROS can stress the cell structure leading to damaged DNA/RNA, decreased membrane activity, disrupted metabolic activity, and harmful side reactions generating chemicals such as peroxides.[4][5] ROS production has been induced generally through the introduction of both metal oxide and positively charged metal nano particles in the cell, such as iron oxides and silver. The positive charge of the metal is attracted to the negative charge of the cell membrane which it then easily penetrates. Redox reactions take place in the cell between the metals and oxygen containing species in the cell to produce ROS.[6] Other novel techniques include utilizing quantum dots such as cadmium telluride, under a bright light source to excite and release electrons; this process initializes ROS production similar to the metal nano particles. [4]

Carbon Structures[edit]

Carbon nano structures such as graphene oxide (GO) sheets, nano tubes, and fullerenes have proven antimicrobial properties when used synergistically with other methods. UV radiation directed at GO sheets, for example, disrupts bacterial cell activity and colony growth via ROS production. Doping nano tubes or fullerenes with silver or copper nano particles may also harm the cells ability to grow and replicate DNA. [7] Nano tubes and fullerenes in particular are being studied as aqueous dispersions rather than polymers, metals or other traditional dry solid particulates. The exact mechanism which promotes this synergy is not clearly understood but it is believe to be linked to the unique surface chemistry of carbon nanostrctures (i.e. the large aspect ratio of carbon nanotubes, high surface energy in GO sheets). Human applications of carbon nano materials have not been tested due to the unknown potential hazards. Current research on the carcinogenic effects, if any, of carbon nanostructures is still in its infancy and there is therefore no clear consensus on the topic. [8]

Drug Synergies[edit]

Nano particles can enhance the effects of traditional antibiotics which a bacteria may have become resistant to and decrease the overall minimum inhibitory concentration (MIC) required for a drug. Silver nano particles have demonstrated improved activity of amoxicillin, penicillin, and gentamicin in bacteria by altering membrane permeability and improving drug delivery. [9] Nano particles themselves may have antimicrobial properties enhanced or induced with the addition of organic drugs. Gold particles, while not inherently antimicrobial, were discovered to express antimicrobial properties when functionalized with ampicillin. [10] In addition to this, gold nano particles demonstrated improved membrane permeability with the addition of 4,6-diamino-2-pyrimidenthiol (DAPT) and non-antiobiotic amines (NAA) to their surfaces. [11]

References[edit]

  1. ^ a b Kandi, Venkataramana; Kandi, Sabitha (2015-04-17). "Antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance". Epidemiology and Health. 37. doi:10.4178/epih/e2015020. ISSN 2092-7193. PMC 4459197. PMID 25968114.{{cite journal}}: CS1 maint: PMC format (link)
  2. ^ Hajipour, Mohammad J.; Fromm, Katharina M.; Akbar Ashkarran, Ali; Jimenez de Aberasturi, Dorleta; Larramendi, Idoia Ruiz de; Rojo, Teofilo; Serpooshan, Vahid; Parak, Wolfgang J.; Mahmoudi, Morteza (2012-10-01). "Antibacterial properties of nanoparticles". Trends in Biotechnology. 30 (10): 499–511. doi:10.1016/j.tibtech.2012.06.004.
  3. ^ Allahverdiyev, Adil M.; Kon, Kateryna Volodymyrivna; Abamor, Emrah Sefik; Bagirova, Malahat; Rafailovich, Miriam (2011-11-01). "Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents". Expert Review of Anti-Infective Therapy. 9 (11): 1035–1052. doi:10.1586/eri.11.121. ISSN 1744-8336. PMID 22029522.
  4. ^ a b Bennington-Castro, Joseph (2016-03-01). "Bio Focus: Light-activated quantum dots kill antibiotic-resistant superbugs". MRS Bulletin. 41 (3): 178–179. doi:10.1557/mrs.2016.35. ISSN 0883-7694.
  5. ^ Huh, Ae Jung; Kwon, Young Jik (2011-12-10). ""Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era". Journal of Controlled Release: Official Journal of the Controlled Release Society. 156 (2): 128–145. doi:10.1016/j.jconrel.2011.07.002. ISSN 1873-4995. PMID 21763369.
  6. ^ Cheng, Guyue; Dai, Menghong; Ahmed, Saeed; Hao, Haihong; Wang, Xu; Yuan, Zonghui (2016-04-08). "Antimicrobial Drugs in Fighting against Antimicrobial Resistance". Frontiers in Microbiology. 7. doi:10.3389/fmicb.2016.00470. ISSN 1664-302X. PMC 4824775. PMID 27092125.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  7. ^ Tegou, Evangelia; Magana, Maria; Katsogridaki, Alexandra Eleni; Ioannidis, Anastasios; Raptis, Vasilios; Jordan, Sheldon; Chatzipanagiotou, Stylianos; Chatzandroulis, Stavros; Ornelas, Catia (2016-05-01). "Terms of endearment: Bacteria meet graphene nanosurfaces". Biomaterials. 89: 38–55. doi:10.1016/j.biomaterials.2016.02.030.
  8. ^ Rittinghausen, Susanne; Hackbarth, Anja; Creutzenberg, Otto; Ernst, Heinrich; Heinrich, Uwe; Leonhardt, Albrecht; Schaudien, Dirk (2014-11-20). "The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats". Particle and Fibre Toxicology. 11: 59. doi:10.1186/s12989-014-0059-z. ISSN 1743-8977. PMC 4243371. PMID 25410479.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  9. ^ Smekalova, Monika; Aragon, Virginia; Panacek, Ales; Prucek, Robert; Zboril, Radek; Kvitek, Libor (2016-03-01). "Enhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogens". Veterinary Journal (London, England: 1997). 209: 174–179. doi:10.1016/j.tvjl.2015.10.032. ISSN 1532-2971. PMID 26832810.
  10. ^ Brown, Ashley N.; Smith, Kathryn; Samuels, Tova A.; Lu, Jiangrui; Obare, Sherine O.; Scott, Maria E. (2012-04-15). "Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus". Applied and Environmental Microbiology. 78 (8): 2768–2774. doi:10.1128/AEM.06513-11. ISSN 0099-2240. PMC 3318834. PMID 22286985.{{cite journal}}: CS1 maint: PMC format (link)
  11. ^ Zhao, Yuyun; Chen, Zeliang; Chen, Yanfen; Xu, Jie; Li, Jinghong; Jiang, Xingyu (2013-09-04). "Synergy of Non-antibiotic Drugs and Pyrimidinethiol on Gold Nanoparticles against Superbugs". Journal of the American Chemical Society. 135 (35): 12940–12943. doi:10.1021/ja4058635. ISSN 0002-7863.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Adel_Attari/sandbox&oldid=774612011"